Estrella Immunopharma, Inc.

Estrella Immunopharma, Inc.verified

ESLA

Price:

$1.06

Market Cap:

$45.62M

Estrella Immunopharma, Inc. is an early-stage biopharmaceutical enterprise focused on creating T-cell therapies for various blood cancers and solid tumors, with its primary activities centered in the United States. The company's lead investigational drugs include EB103, which is in preclinical development for diffuse large B-cell lymphoma, and EB104, intended for the treatment of both diffuse large B-cell lymphoma and acute lymphocytic leukemia. Estrella also maintains a collaborative agreement with Imugene Limited, working together to develop solid tumor therapies that integrate Imugene's CF33-CD19t product candidate with Estrella's EB103. The company is based in Emeryville, California.

Industry

Biotechnology

IPO Date

2021-09-14

Stock Exchange

NASDAQ

Ticker

ESLA

The ROE as of June 2026 (TTM) for Estrella Immunopharma, Inc. (ESLA) is 167.91%

According to Estrella Immunopharma, Inc.’s latest financial reports and current stock price. The company's current ROE is 167.91%. This represents a change of 255.00% compared to the average of 47.30% of the last 4 quarters.

Estrella Immunopharma, Inc. (ESLA) Historical ROE (quarterly & annually)

How has ESLA ROE performed in the past?

The mean historical ROE of Estrella Immunopharma, Inc. over the last ten years is -1008.79%. The current 167.91% ROE has changed -116.64% with respect to the historical average. Over the past ten years (40 quarters), ESLA's ROE was at its highest in in the March 2025 quarter at 114.93%. The ROE was at its lowest in in the December 2024 quarter at -730.73%.

Quarterly (TTM)
Annual

Average

-1008.79%

Median

-7.04%

Minimum

-6155.69%

Maximum

162.08%

Estrella Immunopharma, Inc. (ESLA) ROE by Quarter and Year

Discovering the peaks and valleys of Estrella Immunopharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = Infinity%

Maximum Annual ROE = 162.08%

Minimum Annual Increase = -108.69%

Minimum Annual ROE = -6155.69%

Quarterly (TTM)
Annual
YearROEChange
2025126.02%-102.05%
2024-6155.69%3.50%
2024-171.09%1.11%
2022-14.09%-108.69%
2022162.08%Infinity%

Estrella Immunopharma, Inc. (ESLA) Average ROE

How has ESLA ROE performed in the past?

The current ROE of Estrella Immunopharma, Inc. (ESLA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-2066.92%

5-year avg

-1210.55%

10-year avg

-1008.79%

Estrella Immunopharma, Inc. (ESLA) ROE vs. Peers

How is ESLA’s ROE compared to its peers?

Estrella Immunopharma, Inc.’s ROE is greater than eXoZymes, Inc. (-220.64%), greater than Greenwich LifeSciences, Inc. (-814.48%), greater than Atossa Therapeutics, Inc. (-84.91%), less than Surrozen, Inc. (309.79%), greater than Anebulo Pharmaceuticals, Inc. (-74.58%), less than Tevogen Bio Holdings Inc. (241.39%), less than Oncolytics Biotech Inc. (5.21%), greater than Instil Bio, Inc. (-39.76%), greater than Tiziana Life Sciences Ltd (-125.84%), greater than Immix Biopharma, Inc. (-73.23%),

Build a custom stock screener for Estrella Immunopharma, Inc. (ESLA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Estrella Immunopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Estrella Immunopharma, Inc. (ESLA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Estrella Immunopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Estrella Immunopharma, Inc.'s ROE?

How is the ROE calculated for Estrella Immunopharma, Inc. (ESLA)?

What is the highest ROE for Estrella Immunopharma, Inc. (ESLA)?

What is the 3-year average ROE for Estrella Immunopharma, Inc. (ESLA)?

What is the 5-year average ROE for Estrella Immunopharma, Inc. (ESLA)?

How does the current ROE for Estrella Immunopharma, Inc. (ESLA) compare to its historical average?